10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001193125-15-370225`
Period End Date	20150930
Filing Date	20151106
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	agio-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 54 Cash Flow Statement 60 Comprehensive Income 12

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$71.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$80.05M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.03M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$70.05M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$272.32M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$328.03M	USD	Point-in-time
Collaboration receivable - related party	`DueFromRelatedPartiesCurrent`	$6.49M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Collaboration receivable - related party	`DueFromRelatedPartiesCurrent`	$9.08M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Tenant improvement and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$2.33M	USD	Point-in-time
Tenant improvement and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$2.99M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.61M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.10M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.81M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.22M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.61M	shares	Point-in-time
Refundable income taxes	`IncomeTaxesReceivable`	$3.84M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$371.66M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$359.55M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$125.38M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$55.62M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.39M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$21.13M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$678.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$590.00K	USD	Point-in-time
Total assets	`Assets`	$449.09M	USD	Point-in-time
Total assets	`Assets`	$491.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.97M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.07M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.03M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$15.98M	USD	Point-in-time
Deferred revenue - related party	`DeferredRevenueCurrent`	$35.69M	USD	Point-in-time
Deferred revenue - related party	`DeferredRevenueCurrent`	$22.65M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$310.00K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$2.15M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$61.09M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$49.76M	USD	Point-in-time
Deferred revenue, net of current portion - related party	`DeferredRevenueNoncurrent`	$2.73M	USD	Point-in-time
Deferred revenue, net of current portion - related party	`DeferredRevenueNoncurrent`	$6.24M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$17.43M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$3.72M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 37,605,377 and 37,100,513 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$37.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 37,605,377 and 37,100,513 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$38.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$619.45M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$591.33M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$225.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-57.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-244.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-166.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$375.66M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$424.37M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$491.90M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$449.09M	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
Cost reimbursement from related party	`ReimbursementOfResearchAndDevelopmentRelatedPartyCost`	$7.82M	USD	1 Quarter
Collaboration revenue - related party	`RevenueFromRelatedParties`	$5.48M	USD	1 Quarter
Collaboration revenue - related party	`RevenueFromRelatedParties`	$50.72M	USD	3 Qtrs
Collaboration revenue - related party	`RevenueFromRelatedParties`	$33.90M	USD	1 Quarter
Cost reimbursement from related party	`ReimbursementOfResearchAndDevelopmentRelatedPartyCost`	$16.73M	USD	3 Qtrs
Collaboration revenue - related party	`RevenueFromRelatedParties`	$52.90M	USD	3 Qtrs
Research and development (net of $7,817 and $16,729 of cost reimbursement from related party for the three and nine months ended September 30, 2015, respectively)	`ResearchAndDevelopmentExpense`	$104.89M	USD	3 Qtrs
Research and development (net of $7,817 and $16,729 of cost reimbursement from related party for the three and nine months ended September 30, 2015, respectively)	`ResearchAndDevelopmentExpense`	$65.51M	USD	3 Qtrs
Research and development (net of $7,817 and $16,729 of cost reimbursement from related party for the three and nine months ended September 30, 2015, respectively)	`ResearchAndDevelopmentExpense`	$36.03M	USD	1 Quarter
Research and development (net of $7,817 and $16,729 of cost reimbursement from related party for the three and nine months ended September 30, 2015, respectively)	`ResearchAndDevelopmentExpense`	$25.53M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$12.62M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.93M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$25.81M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.17M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$78.13M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$30.69M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$130.70M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$45.95M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$3.21M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-27.41M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-77.80M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-40.48M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$118.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$48.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$692.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$218.00K	USD	1 Quarter
Income (loss) before benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.26M	USD	1 Quarter
Income (loss) before benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.26M	USD	1 Quarter
Income (loss) before benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-77.11M	USD	3 Qtrs
Income (loss) before benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-27.29M	USD	3 Qtrs
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-448.00K	USD	1 Quarter
Benefit for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Benefit for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-448.00K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-40.26M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-26.84M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-77.11M	USD	3 Qtrs
Net income (loss) per share - basic	`EarningsPerShareBasic`	$-2.06	USD	3 Qtrs
Net income (loss) per share - basic	`EarningsPerShareBasic`	$-1.07	USD	1 Quarter
Net income (loss) per share - basic	`EarningsPerShareBasic`	$0.11	USD	1 Quarter
Net income (loss) per share - basic	`EarningsPerShareBasic`	$-0.81	USD	3 Qtrs
Net income (loss) per share - diluted	`EarningsPerShareDiluted`	$-1.07	USD	1 Quarter
Net income (loss) per share - diluted	`EarningsPerShareDiluted`	$-0.81	USD	3 Qtrs
Net income (loss) per share - diluted	`EarningsPerShareDiluted`	$-2.06	USD	3 Qtrs
Net income (loss) per share - diluted	`EarningsPerShareDiluted`	$0.10	USD	1 Quarter
Weighted-average number of common shares used in net income (loss) per share - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	34.50M	shares	1 Quarter
Weighted-average number of common shares used in net income (loss) per share - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	33.18M	shares	3 Qtrs
Weighted-average number of common shares used in net income (loss) per share - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.35M	shares	3 Qtrs
Weighted-average number of common shares used in net income (loss) per share - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.51M	shares	1 Quarter
Weighted-average number of common shares used in net income (loss) per share - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.35M	shares	3 Qtrs
Weighted-average number of common shares used in net income (loss) per share - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	33.18M	shares	3 Qtrs
Weighted-average number of common shares used in net income (loss) per share - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.59M	shares	1 Quarter
Weighted-average number of common shares used in net income (loss) per share - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.51M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-40.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.84M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$3.70M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-77.11M	USD	3 Qtrs
Depreciation	`Depreciation`	$1.00M	USD	3 Qtrs
Depreciation	`Depreciation`	$2.20M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$6.78M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$22.61M	USD	3 Qtrs
Net amortization of premium on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-431.00K	USD	3 Qtrs
Net amortization of premium on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-412.00K	USD	3 Qtrs
Collaboration receivable - related party	`IncreaseDecreaseInDueFromRelatedPartiesCurrent`	$18.28M	USD	3 Qtrs
Collaboration receivable - related party	`IncreaseDecreaseInDueFromRelatedPartiesCurrent`	$2.58M	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$659.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.32M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.76M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.35M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.32M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.47M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.41M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-15.55M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-80.00K	USD	3 Qtrs
Refundable income taxes and income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-5.30M	USD	3 Qtrs
Refundable income taxes and income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.84M	USD	3 Qtrs
Deferred revenue - related party	`IncreaseDecreaseInDeferredRevenue`	$-9.52M	USD	3 Qtrs
Deferred revenue - related party	`IncreaseDecreaseInDeferredRevenue`	$-12.44M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-51.58M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-46.42M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	$215.38M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	$218.66M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$343.99M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$169.50M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.98M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$727.00K	USD	3 Qtrs
Release of restricted cash	`DecreaseInRestrictedCash`	$571.00K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-46.03M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$107.35M	USD	3 Qtrs
Net proceeds from public offering of common stock, (payment of) commissions and offering costs	`ProceedsFromPaymentsOfIssuanceOfCommonStockCommissionsAndOfferingCosts`	$94.69M	USD	3 Qtrs
Net proceeds from public offering of common stock, (payment of) commissions and offering costs	`ProceedsFromPaymentsOfIssuanceOfCommonStockCommissionsAndOfferingCosts`	$-207.00K	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromStockOptionsExercised`	$1.42M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromStockOptionsExercised`	$5.29M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$5.09M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$96.10M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.51M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$66.02M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$71.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$80.05M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$14.03M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$70.05M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$71.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$80.05M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$14.03M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$70.05M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$6.00M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$5.96M	USD	3 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$197.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.08M	USD	3 Qtrs
Vesting of restricted stock	`VestingOfRestrictedStockValueIncreaseDecrease`	$-7.00K	USD	3 Qtrs
Vesting of restricted stock	`VestingOfRestrictedStockValueIncreaseDecrease`	$-6.00K	USD	3 Qtrs
Proceeds from stock option exercises in other current assets	`ProceedsFromStockOptionsExercisedInOtherCurrentAssets`	$184.00K	USD	3 Qtrs
Proceeds from stock option exercises in other current assets	`ProceedsFromStockOptionsExercisedInOtherCurrentAssets`	$200.00K	USD	3 Qtrs

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-40.26M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-26.84M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-77.11M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$39.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$37.00K	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$282.00K	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-26.80M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-76.83M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-40.25M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$3.74M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.